R. Liedman

Endometrial expression of vasopressin, oxytocin and their receptors in patients with primary dysmenorrhoea and healthy volunteers at ovulation.

S. Hansson, M. Åkerlund, S. Igidbashian, 2008, European journal of obstetrics, gynecology, and reproductive biology.

Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects

S. Hansson, M. Åkerlund, S. Igidbashian, 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Validation of a test model of induced dysmenorrhea

I. James, M. Åkerlund, L. Skillern, 2006, Acta obstetricia et gynecologica Scandinavica.

Intrauterine pressure, ischemia markers, and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin‐induced dysmenorrhea

I. James, M. Åkerlund, S. Igidbashian, 2006, Acta obstetricia et gynecologica Scandinavica.

Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen.

J. Ranstam, C. Ingvar, R. Willén, 2000, Anticancer research.

Myometrial oxytocin receptor mRNA concentrations at preterm and term delivery – the influence of external oxytocin

S. Hansson, M. Åkerlund, S. Igidbashian, 2009, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Endometrial thickness and ovarian cysts as measured by ultrasound in asymptomatic postmenopausal breast cancer patients on various adjuvant treatments including tamoxifen.

J. Ranstam, C. Ingvar, R. Willén, 1997, Anticancer research.

Histopathologic findings in thickened endometria, as measured by ultrasound in asymptomatic, postmenopausal breast cancer patients on various adjuvant treatment including tamoxifen.

J. Ranstam, C. Ingvar, R. Willén, 1998, Anticancer research.